Skip to Main Content

Paper Details

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.
2
2023
AML, Acute Myeloid Leukemia, Atovaquone, PDX models, PJP, Patients, atovaquone, leukemia, mouse, patient, patients, pediatric
Author NameAffiliation
Susan G HilsenbeckDuncan Comprehensive Cancer Center, Baylor College of Medicine
  • 1 - 1

Datasets

Release 1.2